Download PDF
Thromb Haemost 2004; 92(04): 892-893
DOI: 10.1055/s-0037-1614199
Letters to the Editor
Schattauer GmbH

Rebuttal: Factor XII levels, factor XII 46 C>T polymorphism and venous thrombosis: a word of caution is needed

Antonio Girolami
1   University of Padua Medical School, Dept. of Medical and Surgical Sciences, Second Chair of Medicine, Padua, Italy
,
Maria Teresa Sartori
1   University of Padua Medical School, Dept. of Medical and Surgical Sciences, Second Chair of Medicine, Padua, Italy
,
Maria Anna Lombardi
1   University of Padua Medical School, Dept. of Medical and Surgical Sciences, Second Chair of Medicine, Padua, Italy
,
Donatella Pellati
1   University of Padua Medical School, Dept. of Medical and Surgical Sciences, Second Chair of Medicine, Padua, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
15 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Tirado I, Manuel JSoria, Mateo J. et al. Association after linkage analysis indicates that homozygosity for the 46C>T polymorphism in the F12 gene is a genetic risk factor for venous thrombosis. Thromb Haemost 2004; 91: 899-904.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Zeerleder S, Schloesser M, Redondo M. et al. Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency: a study on 73 subjects from 14 Swiss families. Thromb Haemost 1999; 82: 1240-6.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Girolami A, Randi ML, Gavasso S. et al. The occasional venous thrombosis seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: a study of prevalence in 21 patients and review of the literature. J Thromb Thrombolys 2004; 17: 137-41.
    PubMedGoogle Scholar
  • 4 Koster T, Rosendaal FR, Briet E. et al. John Hageman’s factor and deep-vein thrombosis: Leiden thrombophilia study. Br J Haematol 1994; 87: 422-4.
    CrossrefPubMedGoogle Scholar
  • 5 Ratnoff OD, Busse RJ, Sheen RP. The demise 0f Mr.Hageman. New Eng J Med 1968; 279: 760-1.
    CrossrefPubMedGoogle Scholar
  • 6 Gordon EM, Donaldson VH, Saito H. et al. Reduced titers of Hageman factor (factor XII) in Orientals. Ann hitern Med 1981; 95: 697-700.
    PubMedGoogle Scholar
  • 7 Kanaji T, Okamura T, Osaki K. et al. A common genetic polymorphism (46 C to T substitution) in the 5’-untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level. Blood 1998; 91: 2010-4.
    PubMedGoogle Scholar
  • 8 Lane DA, Grant PJ. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 2000; 95: 1517-32.
    PubMedGoogle Scholar
  • 9 Almasy L, MacCluer IW. Association studies of vascular phenotypes. How and why?. Arterioscler Thromb Vasc Biol 2002; 22: 1055-7.
    CrossrefPubMedGoogle Scholar
  • 10 Kitchens CS. The contact system. Arch Pathol Lab Med 2002; 176: 1382-6.
    PubMedGoogle Scholar
  • 11 Miller GJ, Esnouf MP, Burgess Al. et al. Risk of coronary heart disease and activation of factor XII in middle-aged men. Arterioscler Thromb Vasc Biol 1997; 17: 2103-6.
    CrossrefPubMedGoogle Scholar
  • 12 Girolami A, D’Agostino D, Cliffton EE. The effect of ellagic acid on coagulation in vivo. Blood 1966; 27: 93-102.
    PubMedGoogle Scholar
  • 13 Girolami A, Cliffton EE. Hypercoagulable state induced in humans by the intravenous administration of purified ellagic acid. Thromb Diath Haemorrh 1967; 17: 165-75.
    PubMedGoogle Scholar
  • 14 Girolami A, Scarano L, Girolami B. et al. Emphasis on congenital conditions predisposing to thrombosis should not make as disregard. Blood Coagul Fibrinolysis 1999; 09: 659-60.
    PubMedGoogle Scholar